CARRAGEENAN: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Carrageenan is made from parts of various red seaweeds in the Rhodophyceae family. It's commonly used to thicken foods, but it has no nutritional value.

Carrageenan has been added to processed foods since the 1950s. Carrageenan might also help fight infections.

People use carrageenan for cough, common cold, and other conditions, but there is no good scientific evidence to support any uses.

Uses & Effectiveness

Possibly Ineffective for

A sexually transmitted infection that can lead to genital warts or cancer (human papillomavirus or HPV). Applying a carrageen gel before intercourse does not reduce the risk of anal HPV in males who have sex with males.

There is interest in using carrageen for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful.

Side Effects

When taken by mouth: Carrageenan is commonly consumed in foods. A broken down form called poligeenan is possibly unsafe. It might damage the colon and cause bleeding and cancer. But this risk hasn't been shown in humans. Also, carrageenan products found in the US and Europe can only contain a very small amount of this broken down form.

When sprayed into the nose: Carrageenan is possibly safe for most people when used for up to 7 days.

When applied to the skin: There isn't enough reliable information to know if carrageenan is safe. It might cause side effects such as discomfort.

Special Precautions and Warnings

Pregnancy and breast-feeding: Carrageenan is commonly consumed in foods. There isn't enough reliable information to know if it's safe in the larger amounts used as medicine. Stay on the safe side and stick to food amounts.

Bleeding disorders: Carrageenan might slow blood clotting and increase bleeding. Carrageenan might make bleeding disorders worse.

Surgery: Carrageenan might slow blood clotting in some people. Carrageenan might increase the risk for bleeding and interfere with blood pressure control during surgical procedures. Stop using carrageenan at least 2 weeks before a scheduled surgery.

Ulcerative colitis: Carrageenan might increase the risk of relapse in people with ulcerative colitis who are in remission and are on a carrageenan-free diet.

Interactions

Moderate Interaction

Be cautious with this combination

Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs) interacts with CARRAGEENAN
Carrageenan might slow blood clotting. Taking carrageenan along with medications that also slow blood clotting might increase the risk of bruising and bleeding.

Dosing

Carrageenan is commonly added to processed foods.

As medicine, there isn't enough reliable information to know what an appropriate dose of carrageenan might be. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult a healthcare professional before using.

View References

REFERENCES:

Bianchi, M. and Broggini, M. Anti-hyperalgesic effects of nimesulide: studies in rats and humans. Int J Clin.Pract.Suppl 2002;(128):11-19. View abstract.

Buck, C. B., Thompson, C. D., Roberts, J. N., Muller, M., Lowy, D. R., and Schiller, J. T. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS.Pathog. 2006;2(7):e69. View abstract.

Carlucci, M. J., Scolaro, L. A., and Damonte, E. B. Inhibitory action of natural carrageenans on Herpes simplex virus infection of mouse astrocytes. Chemotherapy 1999;45(6):429-436. View abstract.

Carlucci, M. J., Scolaro, L. A., Noseda, M. D., Cerezo, A. S., and Damonte, E. B. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice. Antiviral Res. 2004;64(2):137-141. View abstract.

Coggins, C., Blanchard, K., Alvarez, F., Brache, V., Weisberg, E., Kilmarx, P. H., Lacarra, M., Massai, R., Mishell, D., Jr., Salvatierra, A., Witwatwongwana, P., Elias, C., and Ellertson, C. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sex Transm.Infect. 2000;76(6):480-483. View abstract.

Cummins, J. E., Jr., Guarner, J., Flowers, L., Guenthner, P. C., Bartlett, J., Morken, T., Grohskopf, L. A., Paxton, L., and Dezzutti, C. S. Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob.Agents Chemother. 2007;51(5):1770-1779. View abstract.

Dumelod, B. D., Ramirez, R. P., Tiangson, C. L., Barrios, E. B., and Panlasigui, L. N. Carbohydrate availability of arroz caldo with lambda-carrageenan. Int.J.Food Sci.Nutr. 1999;50(4):283-289. View abstract.

Elias, C. J., Coggins, C., Alvarez, F., Brache, V., Fraser, I. S., Lacarra, M., Lahteenmaki, P., Massai, R., Mishell, D. R., Jr., Phillips, D. M., and Salvatierra, A. M. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan. Contraception 1997;56(6):387-389. View abstract.

Flower, R. J., Harvey, E. A., and Kingston, W. P. Inflammatory effects of prostaglandin D2 in rat and human skin. Br.J Pharmacol. 1976;56(2):229-233. View abstract.

Kilmarx, P. H., van de Wijgert, J. H., Chaikummao, S., Jones, H. E., Limpakarnjanarat, K., Friedland, B. A., Karon, J. M., Manopaiboon, C., Srivirojana, N., Yanpaisarn, S., Supawitkul, S., Young, N. L., Mock, P. A., Blanchard, K., and Mastro, T. D. Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial. J Acquir.Immune.Defic.Syndr. 11-1-2006;43(3):327-334. View abstract.

Maguire, R. A., Bergman, N., and Phillips, D. M. Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex Transm.Dis. 2001;28(5):259-265. View abstract.

Ogino, M., Majima, M., Kawamura, M., Hatanaka, K., Saito, M., Harada, Y., and Katori, M. Increased migration of neutrophils to granulocyte-colony stimulating factor in rat carrageenin-induced pleurisy: roles of complement, bradykinin, and inducible cyclooxygenase-2. Inflamm.Res. 1996;45(7):335-346. View abstract.

Panlasigui, L. N., Baello, O. Q., Dimatangal, J. M., and Dumelod, B. D. Blood cholesterol and lipid-lowering effects of carrageenan on human volunteers. Asia Pac.J.Clin.Nutr. 2003;12(2):209-214. View abstract.

Perotti, M. E., Pirovano, A., and Phillips, D. M. Carrageenan formulation prevents macrophage trafficking from vagina: implications for microbicide development. Biol.Reprod. 2003;69(3):933-939. View abstract.

Tobacman, J. K. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ.Health Perspect. 2001;109(10):983-994. View abstract.

Tobacman, J. K., Wallace, R. B., and Zimmerman, M. B. Consumption of carrageenan and other water-soluble polymers used as food additives and incidence of mammary carcinoma. Med.Hypotheses 2001;56(5):589-598. View abstract.

Watanabe, K., Reddy, B. S., Wong, C. Q., and Weisburger, J. H. Effect of dietary undegraded carrageenan on colon carcinogenesis in F344 rats treated with azoxymethane or methylnitrosourea. Cancer Res. 1978;38(12):4427-4430. View abstract.

Whitehead, S. J., Kilmarx, P. H., Blanchard, K., Manopaiboon, C., Chaikummao, S., Friedland, B., Achalapong, J., Wankrairoj, M., Mock, P., Thanprasertsuk, S., and Tappero, J. W. Acceptability of Carraguard vaginal gel use among Thai couples. AIDS 11-14-2006;20(17):2141-2148. View abstract.

Zacharopoulos, V. R. and Phillips, D. M. Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin.Diagn.Lab Immunol. 1997;4(4):465-468. View abstract.

Bhattacharyya S, Feferman L, Unterman T, Tobacman JK. Exposure to common food additive carrageenan alone leads to fasting hyperglycemia and in combination with high fat diet exacerbates glucose intolerance and hyperlipidemia without effect on weight. J. Diabetes Res. 2015;2015:513429. View abstract.

Bhattacharyya S, Shumard T, Xie H, et al. A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. Nutr Healthy Aging. 2017;4(2):181-92. View abstract.

Eccles R, Meier C, Jawad M, Weinmüllner R, Grassauer A, Prieschl-Grassauer E. Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold. Respir Res. 2010;11:108. View abstract.

Eccles R, Winther B, Johnston SL, Robinson P, Trampisch M, Koelsch S. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial. Respir Res. 2015;16:121. View abstract.

Electronic Code of Federal Regulations. Title 21, Chapter 1, Subchapter B, Part 172: food additives permitted for direct addition to food for human consumption. Available at: https://www.ecfr.gov/cgi-bin/text-idx?SID=59189f37d05de4dda57b07856d8d56f8&mc=true&node=pt21.3.172&rgn=div5#se21.3.172_1515

Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182

European Commission. Opinion of the Scientific Committee on Food on Carrageenan. Available at: https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_scf_out164_en.pdf

Fazekas T, Eickhoff P, Pruckner N, et al. Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold. BMC Complement Altern Med. 2012;12:147. View abstract.

Feferman L, Bhattacharyya S, Oates E, et al. Carrageenan-free diet shows improved glucose tolerance and insulin signaling in prediabetes: a randomized, pilot clinical trial. J Diabetes Res. 2020 Apr 21;2020:8267980. doi: 10.1155/2020/8267980. View abstract.

Fetrow CW, Avila JR. Professional's Handbook of Complementary & Alternative Medicines. 1st ed. Springhouse, PA: Springhouse Corp., 1999.

Figueroa JM, Lombardo ME, Dogliotti A, et al. Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease. Int J Gen Med 2021;14:6277-6286. View abstract.

Hebar A, Koller C, Seifert JM, et al. Non-clinical safety evaluation of intranasal iota-carrageenan. PLoS One. 2015;10(4):e0122911. View abstract.

Laurie C, El-Zein M, Tota JE, et al. Efficacy of a carrageenan gel in preventing anal human papillomavirus (HPV) infection: interim analysis of the Lubricant Investigation in Men to Inhibit Transmission of HPV Infection (LIMIT-HPV) randomised controlled trial. Sex Transm Infect 2021. View abstract.

Ludwig M, Enzenhofer E, Schneider S, et al. Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial. Respir Res. 2013;14:124. View abstract.

Paris quadrifolia L. U.S. National Plant Germplasm System. https://npgsweb.ars-grin.gov/gringlobal/taxonomydetail.aspx?id=410335. Accessed April 30, 2020.

Qiu X, Zhong W. Antihyperglycemic and antihyperlipidemic effects of low-molecular-weight carrageenan in rats. Open Life Sci. 2018;13:379-84. View abstract.

Technical evaluation report: carrageenan. United States Department of Agriculture (USDA) National Organic Program. https://www.ams.usda.gov/sites/default/files/media/Carrageenan%20TR%202011.pdf. Published October 3, 2011. Accessed July 15, 2020.

Zhou J, Wang F, Chen J, et al. Long-term kappa-carrageenan consumption leads to moderate metabolic disorder by blocking insulin binding. Pharmacol Res. 2021 Mar;165:105417. doi: 10.1016/j.phrs.2020.105417. View abstract.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.